Literature DB >> 21407643

The Presence of a Circulating Anti-Coagulant in a Male Member of a Hemophiliac Family.

J S Lawrence, J B Johnson.   

Abstract

Year:  1941        PMID： 21407643      PMCID： PMC2242266     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  4 in total

Review 1.  Key issues in inhibitor management in patients with haemophilia.

Authors:  Keith Gomez; Robert Klamroth; Johnny Mahlangu; Maria E Mancuso; María E Mingot; Margareth Castro Ozelo
Journal:  Blood Transfus       Date:  2013-12-03       Impact factor: 3.443

2.  Attempts to treat patients with hemophilia, the "royal disease".

Authors:  Rojin Park
Journal:  Blood Res       Date:  2013-12

Review 3.  The role of emicizumab, a bispecific factor IXa- and factor X-directed antibody, for the prevention of bleeding episodes in patients with hemophilia A.

Authors:  Tristan Knight; Michael U Callaghan
Journal:  Ther Adv Hematol       Date:  2018-10-10

4.  Product type and other environmental risk factors for inhibitor development in severe hemophilia A.

Authors:  Flora Peyvandi; Isabella Garagiola
Journal:  Res Pract Thromb Haemost       Date:  2018-04-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.